81 related articles for article (PubMed ID: 21954796)
21. Chemotherapy-induced peripheral neuropathy.
Armstrong T; Almadrones L; Gilbert MR
Oncol Nurs Forum; 2005 Mar; 32(2):305-11. PubMed ID: 15759068
[TBL] [Abstract][Full Text] [Related]
22. Oxaliplatin-induced neurotoxicity and the development of neuropathy.
Krishnan AV; Goldstein D; Friedlander M; Kiernan MC
Muscle Nerve; 2005 Jul; 32(1):51-60. PubMed ID: 15880395
[TBL] [Abstract][Full Text] [Related]
23. [Nervous system lesions in subjects with malignant neoplasms].
Sallusto L; De Marco S; Gaita D; Pignatelli F; Lincesso F
Acta Neurol Quad (Napoli); 1981; 42():128-41. PubMed ID: 6267863
[No Abstract] [Full Text] [Related]
24. Grading chemotherapy-induced peripheral neuropathy in adults.
Kaplow R; Iyere K
Nursing; 2017 Feb; 47(2):67-68. PubMed ID: 28121792
[No Abstract] [Full Text] [Related]
25. Oxaliplatin overdosage successfully recovered with mild toxicities.
Muñoz A; Barceló R; Viteri A; Rubio I; De Argumedo GL; López-Vivanco G
Acta Oncol; 2006; 45(5):621-2. PubMed ID: 16864179
[No Abstract] [Full Text] [Related]
26. Adverse effects of cytotoxics-platinum agents.
Selvaratnam G; Philips RH; Mohamed AK; Radzi A
Adverse Drug React Toxicol Rev; 1997 Aug; 16(3):171-97. PubMed ID: 9512763
[No Abstract] [Full Text] [Related]
27. Neurotoxicity of cancer chemotherapy.
Dropcho EJ
Semin Neurol; 2010 Jul; 30(3):273-86. PubMed ID: 20577934
[TBL] [Abstract][Full Text] [Related]
28. Anaphylactic reaction to oxaliplatin: a case report.
Larzillière I; Brandissou S; Breton P; Lingoungou A; Gargot D; Ramain JP; Harnois C
Am J Gastroenterol; 1999 Nov; 94(11):3387-8. PubMed ID: 10566767
[No Abstract] [Full Text] [Related]
29. Oxaliplatin-associated neuropathy: a review.
Cersosimo RJ
Ann Pharmacother; 2005 Jan; 39(1):128-35. PubMed ID: 15590869
[TBL] [Abstract][Full Text] [Related]
30. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
Amara S
Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
[TBL] [Abstract][Full Text] [Related]
31. [Peripheral neuropathy].
Kanemasa Y; Maeda Y
Nihon Rinsho; 2015 Feb; 73 Suppl 2():470-4. PubMed ID: 25831805
[No Abstract] [Full Text] [Related]
32. [Results of a phase-I clinical study of carboplatin--(cyclobutane-1,1-dicarboxylate)diamineplatinum (II)].
Gorbunova VA
Vestn Akad Med Nauk SSSR; 1986; (5):45-7. PubMed ID: 3524054
[No Abstract] [Full Text] [Related]
33. [Revision of the informed consent form for patients based on investigation of adverse events of mFOLFOX6 regimen].
Kato T; Matsunaga Y; Motokawa S; Nakagaki S; Nagata N; Yoshida T; Muramatsu T; Kimura H; Ohashi Y; Kudou Y; Shino M; Yamazaki K; Boku N
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1697-702. PubMed ID: 19838030
[TBL] [Abstract][Full Text] [Related]
34. Oxaliplatin-induced Evan's syndrome.
Earle CC; Chen WY; Ryan DP; Mayer RJ
Br J Cancer; 2001 Feb; 84(3):441. PubMed ID: 11161414
[No Abstract] [Full Text] [Related]
35. Clinical challenges: chemotherapy-induced peripheral neuropathy.
Paice JA
Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S8-19. PubMed ID: 19447319
[TBL] [Abstract][Full Text] [Related]
36. Recurrent priapism related to oxaliplatin infusion.
Adenis A; Mailliez A; Rigot JM; Gamelin L; Vanhuyse M; Gamelin E
J Clin Oncol; 2008 Feb; 26(6):1016-7. PubMed ID: 18281680
[No Abstract] [Full Text] [Related]
37. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
Dragovich T; Mendelson D; Kurtin S; Richardson K; Von Hoff D; Hoos A
Cancer Chemother Pharmacol; 2006 Dec; 58(6):759-64. PubMed ID: 16847673
[TBL] [Abstract][Full Text] [Related]
38. [Lesions of the nervous system in subjects with malignant neoplasms].
Sallusto L; De Marco S; Gaita D; Pignatelli F; Lincesso F
Acta Neurol (Napoli); 1981 Feb; 3(1):128-41. PubMed ID: 6264752
[No Abstract] [Full Text] [Related]
39. Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX).
Jung KH; Kil SY; Choi IK; Seo JH; Shin C; Kim YS; Kim JH
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1181-2. PubMed ID: 17044215
[No Abstract] [Full Text] [Related]
40. Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties.
Ghirardi O; Lo Giudice P; Pisano C; Vertechy M; Bellucci A; Vesci L; Cundari S; Miloso M; Rigamonti LM; Nicolini G; Zanna C; Carminati P
Anticancer Res; 2005; 25(4):2681-7. PubMed ID: 16080512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
